Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $300.68 million. The enterprise value is -$238.60 million.
| Market Cap | 300.68M |
| Enterprise Value | -238.60M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 84.22 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Shares Outstanding | 84.22M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 9.58% |
| Owned by Institutions (%) | 66.88% |
| Float | 64.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.28, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.28 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.20% and return on invested capital (ROIC) is -37.98%.
| Return on Equity (ROE) | -29.20% |
| Return on Assets (ROA) | -27.50% |
| Return on Capital (ROIC) | -37.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.18M |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $1.05 million in taxes.
| Income Tax | 1.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.72% in the last 52 weeks. The beta is 0.18, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -2.72% |
| 50-Day Moving Average | 3.61 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 51.81 |
| Average Volume (20 Days) | 268,239 |
Short Selling Information
The latest short interest is 2.24 million, so 2.66% of the outstanding shares have been sold short.
| Short Interest | 2.24M |
| Short Previous Month | 2.13M |
| Short % of Shares Out | 2.66% |
| Short % of Float | 3.48% |
| Short Ratio (days to cover) | 7.64 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -192.40M |
| Pretax Income | -162.61M |
| Net Income | -163.66M |
| EBITDA | -162.19M |
| EBIT | -162.61M |
| Earnings Per Share (EPS) | -$1.96 |
Balance Sheet
The company has $541.49 million in cash and $2.21 million in debt, giving a net cash position of $539.28 million or $6.40 per share.
| Cash & Cash Equivalents | 541.49M |
| Total Debt | 2.21M |
| Net Cash | 539.28M |
| Net Cash Per Share | $6.40 |
| Equity (Book Value) | 504.37M |
| Book Value Per Share | 5.99 |
| Working Capital | 507.45M |
Cash Flow
| Operating Cash Flow | -95.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | -95.41M |
| FCF Per Share | -$1.14 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
| Earnings Yield | -54.43% |
| FCF Yield | -31.73% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |